Robaxin Injection
Product Images NDC 0641-6217
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Robaxin (NDC 0641-6217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
462-766-00 (Robaxin Injectable Novaplus 2)
This is a description of Robaxin injectable, a prescription medication used to treat muscle spasms and pain. The medication is packaged in a single-dose vial with 1,000 mg of Methocarbamol per 10 mL (100 mg/mL) of solution. The manufacturer is WS Taro, located in Strun, T, and the medication is distributed by NovAPLUS. However, the text is partially unreadable, likely due to errors.*
462-767-00 (Robaxin Injectable Novaplus 3)
This is a description of a medication called ROBAXIN Injection, also known as Methocarbamol Injection. It is sold in single dose vials, each containing 10 mL of the medication. It is intended for intravenous or intramuscular injection and should not be refrigerated. The medication contains Methocarbamol, USP 100mg, Polyethylene glycol 300, NF 0.5 mL, and Water for Injection, USP q.s. pH is adjusted with hydrochloric acid and/or sodium hydroxide. Users should refer to the enclosed statement of directions before using. The product is registered under the trademark NOVAPLUS® by Vize, Inc.*
Robaxin Injectable Novaplus 4
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.